1 Introduction
==============

Hemangiomas are benign vascular tumors of skin, mucosa, muscles, glands, and bones \[[@b1-med-2015-0089]\], and, from a histopathological point of view, are divided into the more common capillary type, mixed types and the less common cavernous type \[[@b2-med-2015-0089]--[@b4-med-2015-0089]\].

Although these tumors are common lesions of the head and neck, they rarely occur in the nasal cavity and paranasal sinuses \[[@b1-med-2015-0089],[@b3-med-2015-0089],[@b5-med-2015-0089]\].

Hemangiomas account for about 20% of all benign tumors of the nasal cavity, mostly arising in the soft tissues and rarely in the bones \[[@b1-med-2015-0089]\].

The cavernous variety of haemangioma described arise from the inferior turbinate \[[@b1-med-2015-0089],[@b4-med-2015-0089],[@b6-med-2015-0089],[@b7-med-2015-0089]\], middle turbinate \[[@b8-med-2015-0089]\], vomer \[[@b9-med-2015-0089]\], lamina perpendicularis ossi ethmoidalis \[[@b10-med-2015-0089]\] and sinus maxillaris \[[@b11-med-2015-0089]\]. To the best of our knowledge, cavernous haemangioma (CA) of the lateral wall of nasopharynx has not previously been reported in literature.

Clinical, radiological and therapeutic management of cavernous haemangioma of nasopharynx, starting from a clinical case that we treated, are herein described.

2 Case report
=============

A 26-year-old woman with a history of recurrent and conspicuous epistaxis and left-sided nasal associated omolateral severe obstruction. The patient underwent several ENT and maxillofacial specialist visits, and arrived to our attention in January 2012 with a diagnosis of "nasopharyngeal cyst polyp-like".

Nasopharynx examination, by flexible endoscopy, showed a cystic mass originating from the left side wall of the nasopharynx. The lesion was in contact with the soft palate, with no other associated anomalies and covered by intact and regular mucosa ([Fig. 1](#f1-med-2015-0089){ref-type="fig"}).

Contrast-enhanced computed tomography (CT) showed a polyp-like mass, adjacent to the left side wall and the rear wall of the nasopharynx, with lamellar calcifications and inhomogeneous enhancement. The maximum transverse diameters of this mass were 22 mm × 12 mm in the axial plane and 27 mm in the sagittal plane; it occupied almost completely the nasopharyngeal lumen, reaching down the oropharynx and the soft palate ([Fig. 2](#f2-med-2015-0089){ref-type="fig"}).

The nasal surgical approach with Functional Endoscopic Sinus Surgery, under general anesthesia, allowed for removal of the mass, measuring 25 × 15 × 10 mm, with bone particles - after careful hemostasis of arterial branches, without complications ([Fig. 3](#f3-med-2015-0089){ref-type="fig"}). Because of the size and the clinical presentation, it was possible to establish the precise site of origin of the tumor at the time of the surgical procedure only.

This procedure consisted of premedication with medicated tampon with xylocaine 1% and epinephrine 1/100000 that was kept in place for 15 minutes. After resection of the tail of the inferior turbinate, the base of the lesion was revealed. The bleeding was controlled by coagulation of the branch of the sphenopalatine artery; using straight scissors, we dissected the base of the tumor using 0° nasal fiber optic; with a Blakesley right clamp, we removed the purplish red mass and performed hemostasis and control of the surgical field.

Ethical approval
----------------

The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board or equivalent committee.

Informed consent
----------------

Informed consent has been obtained from all individuals included in this study.

3 Results
=========

Histopathological study showed mucosa with extensive vascular proliferation, with framework of lacunar/cavernous haemangioma, also present at lamellar bone tissue level ([Fig. 4A, 4B](#f4-med-2015-0089){ref-type="fig"}). The patient followed a satisfactory post-operative course and was discharged within 2 days of hospitalization. No complications occurred during the postoperative period. There was no recurrence of the lesion at 24 months follow-up.

4 Discussion
============

Hemangiomas are benign endothelial lesions without degenerative potential \[[@b12-med-2015-0089]\]. Pathogenesis of these tumors is still unclear. Recently, their origin from late EPCs or differentiated endothelial cells was demonstrated \[[@b13-med-2015-0089]\]. EPCs are mobilized either from the bone marrow or the arterial area to replace dysfunctional endothelial cells and, using different molecular mechanisms, play a pivotal role in blood perfusion of ischemic and tumoral tissues \[[@b14-med-2015-0089]--[@b27-med-2015-0089]\]. Although haemangiomas are common lesions of the head and neck (over half of all hemangiomas are located in this region), in the nasal cavity and paranasal sinuses they are rare \[[@b1-med-2015-0089],[@b3-med-2015-0089],[@b5-med-2015-0089]\]. When they do not involve the soft tissues, but occur as solitary lesions in the bone, they account for less than 1% of all primary bone tumors, usually affecting the vertebral column and the skull bones \[[@b1-med-2015-0089],[@b4-med-2015-0089]\].

Haemangiomas are classified histologically, depending on the dominant vessel size at microscopy, into capillary, mixed and cavernous types \[[@b2-med-2015-0089],[@b3-med-2015-0089],[@b4-med-2015-0089]\]. The latter are composed of large endothelium-lined vascular spaces \[[@b12-med-2015-0089]\]. Thrombi within the vascular spaces may occasionally calcify and are identified at CT as phlebolithes \[[@b28-med-2015-0089]\].

The frequency of the different histological types of hemangiomas is unknown in the literature \[[@b2-med-2015-0089]\]. The relatively broad study, by Osborn in 1959, reviewed 51 patients with haemangiomas of the nose. Of these 51 cases, only two were of the cavernous variety \[[@b29-med-2015-0089]\].

More recently, Iwata \[[@b30-med-2015-0089]\] described three cavernous hemangiomas studied, two having arisen from inferior turbinate.

When these neoplasms arise in the nasal cavity, they are predominantly capillary and arise from the nasal septum in about 80% of the cases, namely in the Little area or Kiesselbach triangle \[[@b29-med-2015-0089]\]. Nasal haemangiomas arise around the fourth decade, with an equal gender incidence \[[@b28-med-2015-0089]\]; moreover they are likely found in the lateral nasal wall and show peculiar histological features \[[@b3-med-2015-0089],[@b19-med-2015-0089],[@b31-med-2015-0089]\].

Cavernous haemangiomas have been described arising from the inferior turbinate \[[@b1-med-2015-0089],[@b4-med-2015-0089],[@b6-med-2015-0089],[@b7-med-2015-0089]\], middle turbinate \[[@b8-med-2015-0089]\], vomer \[[@b9-med-2015-0089]\], *lamina perpendicularis ossi ethmoidalis* \[[@b10-med-2015-0089]\] and *sinus maxillaris* \[[@b11-med-2015-0089]\] but cavernous haemangioma of the lateral wall of the nasopharynx has not previously been reported in literature.

The cause of their intraosseous origin is unclear and a previous local trauma could play a role \[[@b1-med-2015-0089],[@b29-med-2015-0089],[@b32-med-2015-0089]--[@b34-med-2015-0089]\]; the most common symptoms are bleeding, sometimes substantial, and nasal obstruction, which are observed with the progressive growth of the mass. Pain is not characteristic of nasal hemangioma \[[@b7-med-2015-0089],[@b12-med-2015-0089],[@b29-med-2015-0089],[@b32-med-2015-0089]--[@b38-med-2015-0089]\].

The tumor appears as a sessile or polypoid lesion \[[@b29-med-2015-0089]\], as occurred in our case. It usually does not present signs that suggest a vascular lesion \[[@b32-med-2015-0089]--[@b34-med-2015-0089]\].

The unspecific clinical appearance makes it difficult to distinguish hemangiomas from other nasal tumors and malformations, including antrochoanal polyp, inverted papilloma, fibroangioma and lymphangioma \[[@b2-med-2015-0089],[@b29-med-2015-0089]\]. In the presence of irregular mucosa, necrotic tissue or history of previous malignancy, a malignant origin should be suspected (metastases, hemangiopericytoma, hemangiosarcoma) and biopsy should be performed, after clinical-radiological analysis, to exclude a vascular lesion \[[@b6-med-2015-0089],[@b33-med-2015-0089],[@b34-med-2015-0089]\]. In the present case, given the various episodes of epistaxis, no previous biopsy was performed.

Radiographic examination - contrast CT scanningis useful in the definitive pre-operative diagnosis in defining calcifications, bone destruction adjacent to hemangioma, intense enhancement after injection of contrast, anatomical location and extension of the tumor \[[@b2-med-2015-0089],[@b13-med-2015-0089],[@b33-med-2015-0089],[@b34-med-2015-0089]\].

The radiological features, however, do not always give the differential diagnosis with the most common epithelial tumors \[[@b33-med-2015-0089],[@b34-med-2015-0089]\]. Evidence of phleboliths may suggest the presence of a cavernous hemangioma \[[@b34-med-2015-0089]\].

Management of nasal hemangioma involves complete resection of the tumor with a part of underlying mucosa and perichondrium and ligation or cautery to the feeding vessels \[[@b33-med-2015-0089]--[@b35-med-2015-0089],[@b37-med-2015-0089]\]. Choice of the surgical approach depends on the exact site and extension of the tumour ([Tab. 1](#t1-med-2015-0089){ref-type="table"}).

An alternative form of management of these tumours, providing there is favourable anatomy, is embolization of the haemangiomas, which is, however, only possible if appropriate angiographic facilities are available \[[@b6-med-2015-0089]\].

The criteria that lead to embolization, to date, have not been established. According to some authors, embolization would allow, in the case of large hemangiomas, reduced intraoperative bleeding and facilitate the endonasal approach \[[@b2-med-2015-0089]\]. Other authors have witnessed tumour regression following embolization \[[@b6-med-2015-0089]\]. Radiation therapy is reserved for arresting the progression of unresectable or inaccessible lesions \[[@b8-med-2015-0089]\].

Many surgical approaches have been suggested, including lateral rhinotomy, trans-palatal, trans-antral approach and the Le Fort I osteotomy procedure \[[@b35-med-2015-0089],[@b37-med-2015-0089]\].

In the absence of risk of malignant transformation, the trans-nasal endoscopic approach (F.E.S.S.) has been proposed as the technique of choice for the complete removal of the tumor in cases of haemangiomas confined to the nasal cavity and extended into ethmoid to sphenoid sinus \[[@b2-med-2015-0089],[@b35-med-2015-0089],[@b37-med-2015-0089]\].

The choice of wide resection or other effective methods is proposed for the treatment of tumors extending into antrum, pterygomaxillary, infratemporal fossae, orbit, cheek, and cranial cavity \[[@b29-med-2015-0089]\].

The definitive diagnosis is histological. The presence of bone particle and irregular vessel size confirms the diagnosis of cavernous hemangioma \[[@b34-med-2015-0089]--[@b37-med-2015-0089]\]. Followup is necessary in order to identify recurrences, which may occur late \[[@b29-med-2015-0089]--[@b38-med-2015-0089]\]. In conclusion, an unusual site of origin and an unspecific clinical appearance can make the diagnosis and treatment of a cavernous hemangioma of the nasopharynx difficult. In the present case, the minimally invasive trans-nasal endoscopic technique has proven to be reliable in terms of adequate exposure and visualization of the lesion, control of bleeding and complete removal of the tumor.
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![Contrast-enhanced computed tomography (CT) showed a polyp like mass adjacent to the left side wall of nasopharynx.](med-2015-0089f2){#f2-med-2015-0089}
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![A, B. A: Overview: red arrow → respiratory epithelium; green arrow→ small and medium caliber vessels; blu arrow→ large caliber vessels. (hematoxylin-eosin 25×); B: intraosseous portion of the lesion (yellow arrows: bone lamellae) (hematoxylin-eosin 25×).](med-2015-0089f4){#f4-med-2015-0089}

###### 

Cavernous haemangiomas of the nasal cavity and paranasal sinuses reported in the literature.

  Authors                        Site of involvement                          Treatment
  ------------------------------ -------------------------------------------- ------------------------
  ***Takeda et al. 2010***       Inferior turbinate                           Caldwell-Luc procedure
  ***Akiner et al. 2011***       Inferior turbinate                           Endoscopic approach
  ***Webb et al. 2000***         Posterior ends of both inferior turbinates   Embolisation
  ***Archontaki et al. 2008***   Middle nasal meatus                          Endoscopic approach
  ***Bakhos et al. 2008***       Middle turbinate                             Endoscopic approach
  ***Nakahira et al. 1997***     Vomer                                        Le Fort 1 osteotomy
